PHOENIX, Ariz. -- A nationwide shortage of the
prescription drug Ritalin has left some pharmacey shelves bare of
the medication, which many parents say is critical to keeping their
children under control.
Strict federal controls on supplies have parents accross the country
scrambling to find the drug, used mainly to treat children with extreme
hyperactivity and attention-deficit disorder, a learning disability.
Jacque Redfield of Phoenix said her 11-year-old son, Kenneth, was
without his daily dose of the medication for two weeks and nearly
accidently hanged himself.
"He was bouncing off the walls," Redfield, 33, said. "I told him to go
outside and play and work off some of that energy. He hit a
tetherball so hard the cord wrapped around his neck and he was
hanging there in the back yard.
"I hate to think what would have happened if I hadn't been watching
him."
She managed to get a three-week prescription filled on Tuesday,
and she said Kenneth is back on the medication.
"When this runs out, I'm not sure what I'll do," she said.
Several chain pharmacies reported shortages of the drug,
especially in the popular 10-milligram tablet form.
Ritalin is a central-nervous stimulant that helps bring hyperactivity
under control.
About 900,000 patients nationwide, mainly children, take Ritalin or
the generic drug methylphenidate.
It is an amphetimine, and its supply is controlled by the federal
government. Ritalin is in short supply, the manufacturer says,
because the federal Drug Enforcement Administration, which sets
quotas on how much of the drug can be produced, set the amount
too low.
"There is a national shortage," said Todd Forte, a spokesman for
Cib-Geigy Corp. of Summit, N.J., which manufactures Ritalin. "We're
getting calls from all over.
DEA officials in Washington revised the quota Oct. 7, allowing 1,600
additional kilograms of the drug to be produced, bringing the total to
5,000 kilograms for the year. That's up from a total of 1,768 kilograms
in 1990, according to the DEA.
Ciba-Geigy is working "24 hours a day" to manufacture more of the
drug, but it likely will be next month before new shipments reach
pharmacy shelves, Forte said.
Joyce McDonald, a spokewoman for the DEA in Washington, said
there was a delay in revising the quota, usually done at midyear,
because the Justice Department wanted to take a closer look at the
situation.
"There is a great potential for abuse with this drug," she said. "We don't want an overabundance of this drug on the market."
"All of this has put us in a very awkward position," said Dr. Habes
Sawalqah, a Phoenix pediatrician. "This isn't the kind of medication
you can take a child off and put on something else."
Deborah MacLeod, 33, of Scottsdale, said her 10-year-old son,
Alexander, was without medication for only a few days, until she
searched dozens of pharmacies and found a short supply of the
drug.
Without it, she said, her son quickly goes from being a well-behaved
honor-roll student to a child who can't cope int the classroom.
"It's like a Jekyll and Hyde situation," she said.